Feed morbidity-and-mortality-weekly-report-mmwr Morbidity and Mortality Weekly Report (MMWR)

Favorite IconMorbidity and Mortality Weekly Report (MMWR)

Link https://www.cdc.gov/mmwr/index.html
Feed http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Updated 2024-12-26 17:46
Notes from the Field: School-Based Surveillance of Mycoplasma pneumoniae Trends and Impact on School Attendance by Students and Staff Members — Missouri, Fall 2024
This report describes Mycoplasma pneumoniae infections among students and staff of a large public school district in Missouri.
Notes from the Field: Geo-Temporal Trends in Fentanyl Administration Routes Among Adults Reporting Use of Illegally Manufactured Fentanyl When Assessed for Substance-Use Treatment — 14 U.S. Stat
This report describes the percentage of people injecting illegally manufactured fentanyl by route of administration.
Notes from the Field: Long COVID and Significant Long COVID–Associated Activity Limitation Among Adults, by Jurisdiction — United States, 2023
This report describes adults with Long COVID and reported limitations performing daily activities.
Surveillance of Human Adenovirus Types and the Impact of the COVID-19 Pandemic on Reporting — United States, 2017–2023
This report describes a decrease in reporting of human adenoviruses cases to the National Adenovirus Type Reporting System since the COVID-19 pandemic.
QuickStats: Mental Health Treatment Trends Among Adults Aged ≥18 Years, by Age Group — United States, 2019–2023
This report describes mental health treatment trends among adults.
New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024
This report describes CDC's updated recommendations for the MenB-4C vaccine to align the dosing interval and schedule with the new FDA label.
Progress Toward Poliomyelitis Eradication — Afghanistan, January 2023–September 2024
This report describes progress towards eliminating wild poliovirus type 1 in Afghanistan.
Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committ
This report describes CDC's recommendation that all people aged >=65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.
Epidemiology of Dengue — Puerto Rico, 2010–2024
This report describes changing trends among patients with dengue in Puerto Rico.
Surveillance Summaries: Intimate Partner Violence–Related Homicides of Hispanic and Latino Persons — National Violent Death Reporting System, United States, 2003–2021
This report describes data from the National Violent Death Reporting System on intimate partner violence-related homicides of Hispanic and Latino people in the United States from 2003-2021.
QuickStats: Age-Adjusted Percentage of Adults Aged ≥18 Years with Hypertension, by Sex and Race and Ethnicity — United States, August 2021–August 2023
This report describes adults with hypertension by race and ethnicity.
Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season — New York City, 2023–2024
This report describes the percentage of New York City infants born during the recommended nirsevimab adminstration period who received nirsevimab.
Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19–59 Years — United States, 2024
This report describes an update to the recommendation for Hepatitis B vaccination in adults aged 19-59 years.
Intimate Partner Violence and Pregnancy and Infant Health Outcomes — Pregnancy Risk Assessment Monitoring System, Nine U.S. Jurisdictions, 2016–2022
This report describes intimate partner violence among pregnant women and related outcomes.
Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths — United States, 2021–2024
This report describes overdose deaths where illegally manufactured fentanyls, including carfentanil, were detected.
Surveillance Summaries: Waterborne Disease Outbreaks Associated with Splash Pads — United States, 1997–2022
This report characterizes waterborne disease outbreaks associated with splash pads reported to CDC during 1997-2022.
SURVEILLANCE SUMMARIES: Abortion Surveillance — United States, 2022
This report describes abortion rates and ratios (number of abortions per 1,000 live births) in the United States during 2013-2022.
Notes from the Field: Increase in Diagnoses of Human Parvovirus B19–Associated Aplastic Crises in Children and Adolescents with Sickle Cell Disease — Atlanta, Georgia, December 14, 2023&nd
This report describes a higher incidence rate of human parvovirus B19-associated aplastic crises among children and adolescents with sickle cell disease.
Notes from the Field: Human Parvovirus B19 Infections Among Pregnant Persons — Minnesota, January–September 2024
This report describes an increase in the frequency of human parvovirus B19 infections among pregnant women in Minnesota.
Severe and Fatal Rocky Mountain Spotted Fever After Exposure in Tecate, Mexico — California, July 2023–January 2024
This report describes six cases of Rocky Mountain spotted fever among people who were exposed in Tecate, Mexico.
Progress Toward UNAIDS Global HIV Pre-Exposure Prophylaxis Targets: CDC-Supported Oral Pre-Exposure Prophylaxis — 37 Countries, 20172023
This report describes PrEP initiations in 37 countries as part of the United Nations Programme on HIV/AIDS.
Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024
This report describes an increase in positive human parvovirus B19 laboratory test results in 2024 compared to 2018-2019.
QuickStats: Age-Adjusted Percentage of Adults Aged ≥18 Years with Diagnosed Chronic Obstructive Pulmonary Disease, by Urbanization Level — United States, 2023
This report describes the percentage of adults with diagnosed chronic obstructive pulmonary disease.
Notes from the Field: Trends in Emergency Department Visits for Firearm Injuries — United States, January 2018–December 2023
This report describes trends in emergency department visits for firearm injuries between 2018-2023.
Detection of Real-Time Changes in Direction of COVID-19 Transmission Using National- and State-Level Epidemic Trends Based on Rt Estimates — United States Overall and New Mexico, April–Oct
This report describes trend categories and nowcasting that provided an early indication of COVID-19 transmissions.
Influenza, COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults — United States, Fall 2024
This report describes the percentage of eligible adults who received influenza, COVID-19, and RSV vaccines.
Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024
This report describes the percentage of nursing home residents who received a 2024-2025 COVID-19 vaccine, flu vaccines, and influenza vaccine.
Progress Toward Measles Elimination — Worldwide, 2000–2023
This report describes an update on measles cases and vaccination coverage worldwide.
Pediatric Rash Illness Outbreak with Initial Positive Measles Immunoglobulin M Antibody Test Results — American Samoa, March–July 2023
This report describes instances of positive measles immunoglobulin tests among two children in American Samoa that were later confirmed to be alternative viral etiologies.
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications — United States, 2023–2024
This report describes data from two national influenza surveillance networks on antiviral treatment of hospitalized children and adolescents with influenza.
Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023&ndas
This report describes nirsevimab effectiveness in preventing RSV-associated hospitalizations among children in Alaska's Yukon-Kuskokwim Delta region.
Personal Protective Equipment Use by Dairy Farmworkers Exposed to Cows Infected with Highly Pathogenic Avian Influenza A(H5N1) Viruses — Colorado, 2024
This report describes dairy farmworkers in Colorado who were interviewed about PPE use during work activities around cows infected with highly pathogenic avian influenza.
QuickStats: Percentage of Children and Adolescents Aged 12–17 Years Who Participated in 60 Minutes of Physical Activity Most Days or Every Day, by Daily Hours of Screen Time Use — United S
This report describes the percentage of children and adolescents who did 60 minutes of physical activity most days or every day.
Notes from the Field: Ketamine Detection and Involvement in Drug Overdose Deaths — United States, July 2019–June 2023
This report describes the detection of ketamine in overdose deaths.
Serologic Evidence of Recent Infection with Highly Pathogenic Avian Influenza A(H5) Virus Among Dairy Workers — Michigan and Colorado, June–August 2024
This report describes serologic testing to identify recent highly pathogenic avian influenza infections among dairy workers in two states.
Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024
This report describes cases of dracunculiasis reported during 2023-24.
Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season
This report describes influenza vaccination and COVID-19 vaccination coverage among health care personnel during the 2023-24 respiratory virus season (October 1, 2023-March 31, 2024).
QuickStats: Percentage of Adults Aged ≥18 Years Who Were in Families Having Problems Paying Medical Bills in the Past 12 Months, by Disability Status and Age Group — United States, 2023
This report describes the percentage of adults who were in families having problems paying medical bills in the past 12 months.
Notes from the Field: Trichophyton mentagrophytes Genotype VII — New York City, April–July 2024
This report describes four Trichophyton mentagrophytes gentotype VII infections diagnosed in New York City men who have sex with men.
Routine Vaccination Coverage — Worldwide, 2023
This report provides an update on global immunization coverage.
Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period — Suzhou City, Jiangsu Province, China, 2018–2023
This report describes influenza hospitalization rates among pregnant and postpartum women in China with influenza.
Statewide Outbreak of Neisseria meningitidis Serogroup Y, Sequence Type 1466 — Virginia, 2022–2024
This report describes an outbreak of meningococcal disease in Virginia.
SURVEILLANCE SUMMARIES: Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults — Influenza Hospitalization Surveillance Network, United States, 2010–2023
This report summarizes FluSurv-NET data from the 2010-11 through 2022-23 influenza seasons.
Two Outbreaks of Legionnaires Disease Associated with Outdoor Hot Tubs for Private Use — Two Cruise Ships, November 2022–July 2024
This report describes two outbreaks of Legionnaires reported among travelers of two cruise ships during November 2022-June 2024.
Notes from the Field: First Locally Acquired Dengue Virus Infections — Pasadena, California, October–December 2023
This report describes the public health response after a case of dengue was reported in California.
Locally Acquired (Autochthonous) Mosquito-Transmitted Plasmodium vivax Malaria — Saline County, Arkansas, September 2023
This report describes the public health response to 10 cases of locally acquired mosquito-borne malaria in the U.S.
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024
This report summarizes U.S. trends in variant proportion estimates during May 2023-September 2024, a period when SARS-CoV-2 lineages primarily comprised descendants of Omicron variants XBB and JN.1.
Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2023–24 School Year
This report describes national kindergarten vaccination coverage with state-required vaccinations.
QuickStats: Prevalence of Obesity and Severe Obesity Among Persons Aged 2–19 Years — United States, 1999–2000 Through 2021–2023
This report describes prevalence of obesity and severe obesity among people aged 2-19 years.
Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2023–June 2024
This report describes cases of vaccine-derived polioviruses in 39 countries during January 2023-June 2024.
12345678910...